Case Presentations

A Man with Fevers and Chest Pain
Jigar Patel MD, PGY-3 Internal Medicine

A 42 y/o Hispanic man without significant medical
history presented to the ED with the complaint of
increasing left-sided chest pain. The patient reported that
symptoms began 4 days prior, when he developed a
severe headache. That night, he noted increasing chills
and sweats, with a fever measured at 103 degrees F. The
following morning, he developed left-sided chest pain
that he described as a pressure exacerbated by movement
and breathing. For the next several days, he reported
feeling worse with continuous chills and fever spikes up
to 105 degrees F, along with increased severity and
duration of his chest pain.
The patient mentioned that acetaminophen and overthe-counter analgesics did not relieve his symptoms.
With his chest pain, he also noted associated shortness
of breath with mild nausea. However, he denied
abdominal pain or changes in his bowel habits, and he
reported that his weight had been stable. He had never
had these symptoms before.
The patient’s past medical history was remarkable for a
trauma-related leg fracture in 1995 that was repaired by
open reduction and internal fixation. He also had oral
surgery in 2000 for severe periodontitis and subsequently
had to have a full mouth extraction.
He denied alcohol, tobacco or illicit drug use. He was
married for 18 years with 2 healthy children. He denied
any HIV risk factors. He also did not report any recent
travel or exposure to known sick individuals. He worked
at a surgical instrument manufacturing plant.
On admission, his vital signs were: blood pressure 99/62,
pulse 133, respirations 22, temperature 99.6 degrees F
and oxygenation saturation 96% on room air. He
appeared to be acutely ill, although alert and cooperative
to exam. His pupils were equal and reactive with normal
extraocular movements. He had complete maxillary and
mandibular dentures and dry mucus membranes.
Cardiac exam revealed a normal S1 and S2, regular rate
without appreciable murmurs. Notable findings on lung
exam were bibasilar rales. His abdomen was benign, and
he did not have evidence of rash or lesions.

An electrocardiogram revealed sinus tachycardia with a
rate of 127. Chest x-ray showed bilateral interstitial
opacities involving middle and lower lung fields suggestive
of an atypical infectious process. There was no
cardiomegaly, pulmonary edema or pleural effusions.
Laboratory data indicated normal chemistries, a white
blood cell count of 14.5 with 84% neutrophils, and 4%
bands. Platelets were decreased at 47,000. Cardiac markers
were all normal. The INR was 1.23 with a PTT of 36.
A presumptive diagnosis of community-acquired versus
atypical pneumonia was made and the patient was
rehydrated and started on iv moxifloxacin. The night of
admission, the patient’s clinical status quickly
deteriorated with increasing oxygen requirements up to
5 liters via nasal cannula, with oxygen saturations in the
low 90% range. Complete blood count drawn the next
morning revealed a white blood cell count of 16.1 and
platelets at 35,000. Physical exam the next day was
noteworthy for a new systolic ejection murmur heard
best at the apex with radiation to the axilla. A thorough
skin exam revealed characteristic splinter hemorrhages
and Janeway lesions on the palmer surface of hands and
the soles of the feet (See Figures F and G, Color Plates
page 19). A formal fundoscopic exam revealed Roth’s
spots in both eyes. A transthoracic echocardiogram was
done, which showed a 1.6 cm x 1.4 cm mass attached to
the lateral base of the posterior leaflet of the mitral valve.
The mass was noted to be smooth with no projections.
It was felt to be rather unusual and atypical for a
vegetation. The ejection fraction was normal. Admission
blood cultures came back positive for gram positive cocci
in clusters. A DIC panel showed increased D-dimer,
decreased fibrinogen and elevated INR.
The clinical picture was most consistent with acute
bacterial endocarditis. The patient was started
empirically on vancomycin and gentamycin.
He continued to do poorly with higher oxygen
requirements to maintain saturations greater than 90%.
A portable chest x-ray showed frank pulmonary edema.
The patient was urgently transferred to the cardiac care
unit with presumed mitral valve failure, secondary to the
vegetation. His blood pressures were controlled with
nipride and hydralazine and he was aggressively diuresed
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with iv furosemide. The antibiotic regimen was
broadened to include Rifampin. Unfortunately, he did
not improve clinically. Multiple blood cultures continued
to show Staphylococcus aureus, despite several days of
antibiotic therapy. The decision was made, in
consultation with Cardiac Surgery, to take the patient to
the operating room for emergent mitral valve
replacement. Intraoperativly, a 2 cm x 2 cm friable
vegetation was noted at the posterior leaflet of the mitral
valve. There was also a large abscess cavity burrowing
into the annulus destroying about 2/3 of the posterior
annulus. Histopathology revealed Staph aureus colonies
embedded within the vegetation (See Figures H-J, Color
Plates page 19). Postoperatively, the patient did well for
the next 48 hours, and was deemed stable for transfer
out of the cardiothoracic critical care unit. Shortly
thereafter, he again developed temperature spikes, with
persistently positive blood cultures despite re-initiation
of antibiotics. On post-op day 7, he had an acute episode
of shortness of breath with evidence of pulmonary
edema, requiring reintubation. It was determined that
his prosthetic mitral valve had been reinfected and was
failing. Despite all heroic efforts, the patient ultimately
succumbed to sepsis.
Discussion
Infective endocarditis (IE) is defined as an infection
which can produce vegetations on the endocardium,
including valves, septae, or mural endocardium. IE is
almost invariably fatal, if untreated. An estimated 10,000
to 15,000 new cases of IE are diagnosed in the USA each
year, with male to female ratios ranging from 2:1 to as
high as 9:1. IE can be broadly classified into native valve
and prosthetic valve infection, with subdivisions within
each category based on the microorganism (further classifications can also be made based on the nature of the
infected valve; this will be expounded further in treatment
options). Although native valve endocarditis can be
caused by almost any kind of bacteria, the three most
common include streptococci, staphylococci and
enterococci. The HACEK organisms (Haemophilus,
Actinobacillus, Cardiobacterium, Eikenella, and Kingella)
are oral flora that cause a subacute presentation and are
very difficult to grow on media, hence the term ‘culture
negative’ endocarditis. In patients who have indwelling

catheters and/or are immunocompromised, fungal IE can
occur with Candidia and Aspergillus species. Prosthetic
valves predispose to endocarditis. In one study, IE of
prosthetic valves accounted for 10-20 percent of cases. In
addition to valves, intravascular sutures and pacemaker
wires can also become foci of infection. Early onset
prosthetic valve endocarditis (less than 60 days after
surgery) is usually secondary to intraoperative
contamination
or
perioperative
bacteremia.
Approximately half of all cases are caused by
staphylococci, with S. epidermidis more frequent than
S.aureus. Gram negative rods can account for up to 15
percent and fungi up to 10 percent of early cases. When
late endocarditis occurs (onset > 60 days) the organism is
usually a streptococcus species (about 40% of cases). Early
prosthetic IE often runs a fulminant course, with valvular
dysfunction and valve dehiscence. Although late
prosthetic IE can progress similarly, more often the
clinical course resembles non-prosthetic IE with
streptococcus and is luckily not as catastrophic. There are
several known risk factors for the development of IE,
including injection drug use, prosthetic heart valves, and
structural heart disease. Other factors have been
postulated to increase the risk of IE. These form the
theoretical basis for antimicrobial prophylaxis prior to
planned invasive procedures in certain individuals.
Several criteria have been developed for the diagnosis of
IE. It should be noted that the diagnosis is ultimately
based on the clinical picture and compulsory adherence
to set criteria is usually not necessary. That being said,
the Modified Duke Criteria is one of the most commonly
used set of guidelines, using a schema of major and minor
criteria. Major criteria include positive blood cultures for
organisms that cause IE, evidence of endocardial
involvement, suggestive echocardiogram findings, and
new valvular regurgitation. Minor criteria are many and
include: history of intravenous drug use or structural
heart disease, fevers >100.4 degrees F, vascular stigmata
such as Janeway lesions, or septic emboli, immunologic
phenomena such as Osler’s nodes or glomerulonephritis,
and microbiological evidence. A definite diagnosis is
made on either pathological OR clinical criteria. Clinical
criteria usually requires 2 major criteria or 1 major and 3
minor or 5 minor criteria. Possible IE is defined as 1
major and 1 minor OR 3 minor.
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The treatment of IE is dependent on the valve, as well as
the suspected organism. The following table summarizes
the different regimens available to treat IE. (Although
only one choice is presented, it should be noted that
there are alternative antibiotics that can be used for each
type of infection.)

Type of Infection

Antibiotic Choice

Native Valve IE
from PCN sensitive
Streptococcus
Native Valve IE
from PCN resistant
Streptococcus
Standard Therapy
for Endocarditis
due to Enterococcus
Native Valve IE due
to Methicillin Sensitive
Staphylococcus

PCN G 12-18 million
U/24hr OR Ceftriaxone
2gm IV q24h
Vancomycin 30mg/kg
per 24h IV in 2 divided
doses
Ampicillin 12g/24h IV
WITH Gentamycin
1g/kg IV every 8h
Nafcillin/Oxacillin
2gm IV every 4h
WITH Gentamycin
1mg/kg IV every 8h
Vancomycin 30mg/kg
per 24h IV WITH
Rifampin 300mg orally
every 8h WITH
Gentamycin 1mg/kg
IV every 8h
Nafcillin/Oxacillin 2g
IV every 4h WITH
Rifampin 300mg orally
every 8h WITH
Gentamycin 1mg/kg
IV every 8h
Ceftriaxone 2g IV
every 24h

Prosthetic Valve IE
with Methicillin
Resistant
Staphylococcus

Prosthetic Valve IE
with Methicillin
Sensitive
Staphylococcus

Therapy due
to HACEK
Microorganism

Length of
Treatment
4 weeks
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